Intestinal Absorption and Metabolic Characteristics of Sildenafil: a Study Using in Situ Intestinal Administration Rat Model Based on Mass Fragmentation Pathway
礼嵩,倪海涛,盛夏,唐守艳,陆雯静,程春燕,李伟,范国荣,孙颖浩
DOI: https://doi.org/10.3724/sp.j.1008.2014.00061
2014-01-01
Abstract:Objective To investigate the fragmentation pathways of sildenafil and its active metabolite N-desmethylsildenafil,so as to understand the intestinal absorption and metabolic characteristics of sildenafil.Methods Usingelectrospray ion technology(positive ion mode),we analyzed the fragmentation pathways of sildenafil and its active metabolite N-desmethylsildenafil.Based on the rule of cracking,a LC-ESI(+)MS/MS method was developed to determine the intestinal absorption of sildenafil and metabolism of active metabolites N-desmethylsildenafil in the mesenterium.Totally 25 healthy adult male SD rats were randomly divided into five groups and each group contained 5rats.The hepatic portal venous blood samples were obtained from rats after intestinal administration of 10 mg/kg of sildenafil citrate.The absorption and metabolism were examined in the in situintestinal administration model at premedication,0.25h,0.5h,1hand 4h(five groups)after medication.Results Mass spectrometric pyrolysis of sildenafil and its active metabolite N-demethylsildenafil showed ion peaks m/z311and 283,indicating that the C-S bond was unstable and was liable to lose C5H12O2N2S,and the C-O bond was unstable and was liable to lose C2H4,finally forming stable fragment ions.When m/z475→m/z283(sildenafil) and m/z461→m/z283(N-demethylsildenafil)were used as ion reaction channel,sildenafil were absorbed not only in the form of sildenafil in the intestine,but also in the form of its active metabolite N-demethylsildenafil metabolisming as 1/5of the prototype drugs were finally changed into N-demethylsildenafil.Conclusion Both sildenafil and N-demethylsildenafil can be cracked into stable m/z283secondary ions.Intestinal absorption is accompanied by its nitrogen demethylation reaction,which leads to the fact that about 1/5of prototype drug metabolized into active metabolite N-demethylsildenafil.